nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiotropium—CYP3A4—Methylprednisolone—psoriatic arthritis	0.079	0.216	CbGbCtD
Tiotropium—CYP3A4—Triamcinolone—psoriatic arthritis	0.0599	0.164	CbGbCtD
Tiotropium—CYP3A4—Betamethasone—psoriatic arthritis	0.0514	0.14	CbGbCtD
Tiotropium—CYP3A4—Prednisolone—psoriatic arthritis	0.0507	0.139	CbGbCtD
Tiotropium—CYP3A4—Prednisone—psoriatic arthritis	0.0479	0.131	CbGbCtD
Tiotropium—CYP2D6—Dexamethasone—psoriatic arthritis	0.047	0.128	CbGbCtD
Tiotropium—CYP3A4—Dexamethasone—psoriatic arthritis	0.0299	0.0817	CbGbCtD
Tiotropium—Cataract—Triamcinolone—psoriatic arthritis	0.00469	0.0074	CcSEcCtD
Tiotropium—Glaucoma—Prednisone—psoriatic arthritis	0.00468	0.00739	CcSEcCtD
Tiotropium—Constipation—Auranofin—psoriatic arthritis	0.00464	0.00733	CcSEcCtD
Tiotropium—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.00444	0.007	CcSEcCtD
Tiotropium—Urticaria—Auranofin—psoriatic arthritis	0.00431	0.00681	CcSEcCtD
Tiotropium—Abdominal pain—Auranofin—psoriatic arthritis	0.00429	0.00677	CcSEcCtD
Tiotropium—Candida infection—Triamcinolone—psoriatic arthritis	0.00426	0.00672	CcSEcCtD
Tiotropium—Cataract—Betamethasone—psoriatic arthritis	0.00425	0.00671	CcSEcCtD
Tiotropium—Cataract—Dexamethasone—psoriatic arthritis	0.00425	0.00671	CcSEcCtD
Tiotropium—Herpes zoster—Methotrexate—psoriatic arthritis	0.00391	0.00617	CcSEcCtD
Tiotropium—Pruritus—Auranofin—psoriatic arthritis	0.00384	0.00606	CcSEcCtD
Tiotropium—Skin ulcer—Methotrexate—psoriatic arthritis	0.00379	0.00597	CcSEcCtD
Tiotropium—Gingivitis—Methotrexate—psoriatic arthritis	0.00376	0.00592	CcSEcCtD
Tiotropium—Hypercholesterolaemia—Prednisone—psoriatic arthritis	0.00373	0.00588	CcSEcCtD
Tiotropium—Cataract—Prednisone—psoriatic arthritis	0.00371	0.00584	CcSEcCtD
Tiotropium—Vomiting—Auranofin—psoriatic arthritis	0.00345	0.00545	CcSEcCtD
Tiotropium—Rash—Auranofin—psoriatic arthritis	0.00342	0.0054	CcSEcCtD
Tiotropium—Dermatitis—Auranofin—psoriatic arthritis	0.00342	0.0054	CcSEcCtD
Tiotropium—Dry skin—Prednisolone—psoriatic arthritis	0.00323	0.00509	CcSEcCtD
Tiotropium—Nausea—Auranofin—psoriatic arthritis	0.00323	0.00509	CcSEcCtD
Tiotropium—Glossitis—Methotrexate—psoriatic arthritis	0.0032	0.00504	CcSEcCtD
Tiotropium—Dry skin—Betamethasone—psoriatic arthritis	0.00269	0.00425	CcSEcCtD
Tiotropium—Dry skin—Dexamethasone—psoriatic arthritis	0.00269	0.00425	CcSEcCtD
Tiotropium—Mouth ulceration—Methotrexate—psoriatic arthritis	0.00267	0.0042	CcSEcCtD
Tiotropium—Upper respiratory tract infection—Triamcinolone—psoriatic arthritis	0.0026	0.0041	CcSEcCtD
Tiotropium—Epistaxis—Triamcinolone—psoriatic arthritis	0.00236	0.00371	CcSEcCtD
Tiotropium—Visual impairment—Prednisolone—psoriatic arthritis	0.00235	0.0037	CcSEcCtD
Tiotropium—Dry skin—Prednisone—psoriatic arthritis	0.00235	0.0037	CcSEcCtD
Tiotropium—Hyperglycaemia—Betamethasone—psoriatic arthritis	0.00229	0.00362	CcSEcCtD
Tiotropium—Hyperglycaemia—Dexamethasone—psoriatic arthritis	0.00229	0.00362	CcSEcCtD
Tiotropium—Rhinitis—Triamcinolone—psoriatic arthritis	0.00225	0.00354	CcSEcCtD
Tiotropium—Rhinitis—Methylprednisolone—psoriatic arthritis	0.00224	0.00354	CcSEcCtD
Tiotropium—Pharyngitis—Triamcinolone—psoriatic arthritis	0.00222	0.00351	CcSEcCtD
Tiotropium—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.0022	0.00347	CcSEcCtD
Tiotropium—Arrhythmia—Prednisolone—psoriatic arthritis	0.00218	0.00343	CcSEcCtD
Tiotropium—Visual impairment—Methylprednisolone—psoriatic arthritis	0.00216	0.0034	CcSEcCtD
Tiotropium—Eye disorder—Methylprednisolone—psoriatic arthritis	0.00209	0.0033	CcSEcCtD
Tiotropium—Angiopathy—Methylprednisolone—psoriatic arthritis	0.00203	0.0032	CcSEcCtD
Tiotropium—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.00202	0.00319	CcSEcCtD
Tiotropium—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.00202	0.00318	CcSEcCtD
Tiotropium—Arrhythmia—Triamcinolone—psoriatic arthritis	0.002	0.00316	CcSEcCtD
Tiotropium—Vision blurred—Prednisolone—psoriatic arthritis	0.002	0.00315	CcSEcCtD
Tiotropium—Arrhythmia—Methylprednisolone—psoriatic arthritis	0.002	0.00315	CcSEcCtD
Tiotropium—Hyperglycaemia—Prednisone—psoriatic arthritis	0.002	0.00315	CcSEcCtD
Tiotropium—Visual impairment—Dexamethasone—psoriatic arthritis	0.00196	0.00309	CcSEcCtD
Tiotropium—Visual impairment—Betamethasone—psoriatic arthritis	0.00196	0.00309	CcSEcCtD
Tiotropium—Mental disorder—Methylprednisolone—psoriatic arthritis	0.00196	0.00309	CcSEcCtD
Tiotropium—Malnutrition—Methylprednisolone—psoriatic arthritis	0.00195	0.00307	CcSEcCtD
Tiotropium—Angioedema—Prednisolone—psoriatic arthritis	0.00194	0.00306	CcSEcCtD
Tiotropium—Syncope—Prednisolone—psoriatic arthritis	0.0019	0.003	CcSEcCtD
Tiotropium—Eye disorder—Dexamethasone—psoriatic arthritis	0.0019	0.003	CcSEcCtD
Tiotropium—Eye disorder—Betamethasone—psoriatic arthritis	0.0019	0.003	CcSEcCtD
Tiotropium—Back pain—Triamcinolone—psoriatic arthritis	0.00189	0.00298	CcSEcCtD
Tiotropium—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00186	0.00294	CcSEcCtD
Tiotropium—Angiopathy—Dexamethasone—psoriatic arthritis	0.00185	0.00291	CcSEcCtD
Tiotropium—Angiopathy—Betamethasone—psoriatic arthritis	0.00185	0.00291	CcSEcCtD
Tiotropium—Hypertension—Prednisolone—psoriatic arthritis	0.00183	0.00289	CcSEcCtD
Tiotropium—Arrhythmia—Dexamethasone—psoriatic arthritis	0.00182	0.00287	CcSEcCtD
Tiotropium—Arrhythmia—Betamethasone—psoriatic arthritis	0.00182	0.00287	CcSEcCtD
Tiotropium—Angioedema—Triamcinolone—psoriatic arthritis	0.00178	0.00281	CcSEcCtD
Tiotropium—Angioedema—Methylprednisolone—psoriatic arthritis	0.00178	0.00281	CcSEcCtD
Tiotropium—Syncope—Triamcinolone—psoriatic arthritis	0.00175	0.00276	CcSEcCtD
Tiotropium—Syncope—Methylprednisolone—psoriatic arthritis	0.00175	0.00275	CcSEcCtD
Tiotropium—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00174	0.00275	CcSEcCtD
Tiotropium—Oedema—Prednisolone—psoriatic arthritis	0.00173	0.00273	CcSEcCtD
Tiotropium—Dysuria—Methotrexate—psoriatic arthritis	0.00173	0.00273	CcSEcCtD
Tiotropium—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.00172	0.00271	CcSEcCtD
Tiotropium—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00172	0.0027	CcSEcCtD
Tiotropium—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00171	0.0027	CcSEcCtD
Tiotropium—Shock—Prednisolone—psoriatic arthritis	0.0017	0.00269	CcSEcCtD
Tiotropium—Cough—Triamcinolone—psoriatic arthritis	0.0017	0.00269	CcSEcCtD
Tiotropium—Tachycardia—Prednisolone—psoriatic arthritis	0.00169	0.00267	CcSEcCtD
Tiotropium—Hypertension—Triamcinolone—psoriatic arthritis	0.00168	0.00266	CcSEcCtD
Tiotropium—Hypertension—Methylprednisolone—psoriatic arthritis	0.00168	0.00265	CcSEcCtD
Tiotropium—Myalgia—Triamcinolone—psoriatic arthritis	0.00166	0.00262	CcSEcCtD
Tiotropium—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00166	0.00261	CcSEcCtD
Tiotropium—Myalgia—Methylprednisolone—psoriatic arthritis	0.00166	0.00261	CcSEcCtD
Tiotropium—Eye disorder—Prednisone—psoriatic arthritis	0.00166	0.00261	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00165	0.0026	CcSEcCtD
Tiotropium—Dry mouth—Triamcinolone—psoriatic arthritis	0.00162	0.00256	CcSEcCtD
Tiotropium—Renal failure—Methotrexate—psoriatic arthritis	0.00162	0.00256	CcSEcCtD
Tiotropium—Angioedema—Betamethasone—psoriatic arthritis	0.00162	0.00255	CcSEcCtD
Tiotropium—Angioedema—Dexamethasone—psoriatic arthritis	0.00162	0.00255	CcSEcCtD
Tiotropium—Stomatitis—Methotrexate—psoriatic arthritis	0.00161	0.00254	CcSEcCtD
Tiotropium—Angiopathy—Prednisone—psoriatic arthritis	0.00161	0.00253	CcSEcCtD
Tiotropium—Immune system disorder—Prednisone—psoriatic arthritis	0.0016	0.00252	CcSEcCtD
Tiotropium—Oedema—Triamcinolone—psoriatic arthritis	0.00159	0.00251	CcSEcCtD
Tiotropium—Syncope—Dexamethasone—psoriatic arthritis	0.00159	0.0025	CcSEcCtD
Tiotropium—Syncope—Betamethasone—psoriatic arthritis	0.00159	0.0025	CcSEcCtD
Tiotropium—Arrhythmia—Prednisone—psoriatic arthritis	0.00158	0.0025	CcSEcCtD
Tiotropium—Infection—Triamcinolone—psoriatic arthritis	0.00158	0.0025	CcSEcCtD
Tiotropium—Infection—Methylprednisolone—psoriatic arthritis	0.00158	0.00249	CcSEcCtD
Tiotropium—Shock—Triamcinolone—psoriatic arthritis	0.00157	0.00247	CcSEcCtD
Tiotropium—Insomnia—Prednisolone—psoriatic arthritis	0.00157	0.00247	CcSEcCtD
Tiotropium—Shock—Methylprednisolone—psoriatic arthritis	0.00156	0.00247	CcSEcCtD
Tiotropium—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00156	0.00246	CcSEcCtD
Tiotropium—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00156	0.00245	CcSEcCtD
Tiotropium—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00156	0.00245	CcSEcCtD
Tiotropium—Epistaxis—Methotrexate—psoriatic arthritis	0.00156	0.00245	CcSEcCtD
Tiotropium—Paraesthesia—Prednisolone—psoriatic arthritis	0.00155	0.00245	CcSEcCtD
Tiotropium—Tachycardia—Triamcinolone—psoriatic arthritis	0.00155	0.00245	CcSEcCtD
Tiotropium—Mental disorder—Prednisone—psoriatic arthritis	0.00155	0.00245	CcSEcCtD
Tiotropium—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00155	0.00245	CcSEcCtD
Tiotropium—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00154	0.00243	CcSEcCtD
Tiotropium—Malnutrition—Prednisone—psoriatic arthritis	0.00154	0.00243	CcSEcCtD
Tiotropium—Hypertension—Dexamethasone—psoriatic arthritis	0.00153	0.00241	CcSEcCtD
Tiotropium—Hypertension—Betamethasone—psoriatic arthritis	0.00153	0.00241	CcSEcCtD
Tiotropium—Myalgia—Dexamethasone—psoriatic arthritis	0.00151	0.00238	CcSEcCtD
Tiotropium—Myalgia—Betamethasone—psoriatic arthritis	0.00151	0.00238	CcSEcCtD
Tiotropium—Pharyngitis—Methotrexate—psoriatic arthritis	0.00147	0.00232	CcSEcCtD
Tiotropium—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00146	0.00231	CcSEcCtD
Tiotropium—Vision blurred—Prednisone—psoriatic arthritis	0.00145	0.00229	CcSEcCtD
Tiotropium—Urethral disorder—Methotrexate—psoriatic arthritis	0.00145	0.00229	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00145	0.00229	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00145	0.00228	CcSEcCtD
Tiotropium—Oedema—Dexamethasone—psoriatic arthritis	0.00144	0.00228	CcSEcCtD
Tiotropium—Oedema—Betamethasone—psoriatic arthritis	0.00144	0.00228	CcSEcCtD
Tiotropium—Insomnia—Triamcinolone—psoriatic arthritis	0.00144	0.00227	CcSEcCtD
Tiotropium—Insomnia—Methylprednisolone—psoriatic arthritis	0.00144	0.00227	CcSEcCtD
Tiotropium—Infection—Dexamethasone—psoriatic arthritis	0.00144	0.00226	CcSEcCtD
Tiotropium—Infection—Betamethasone—psoriatic arthritis	0.00144	0.00226	CcSEcCtD
Tiotropium—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00143	0.00226	CcSEcCtD
Tiotropium—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00143	0.00225	CcSEcCtD
Tiotropium—Visual impairment—Methotrexate—psoriatic arthritis	0.00143	0.00225	CcSEcCtD
Tiotropium—Shock—Betamethasone—psoriatic arthritis	0.00142	0.00224	CcSEcCtD
Tiotropium—Shock—Dexamethasone—psoriatic arthritis	0.00142	0.00224	CcSEcCtD
Tiotropium—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00142	0.00223	CcSEcCtD
Tiotropium—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00142	0.00223	CcSEcCtD
Tiotropium—Tachycardia—Betamethasone—psoriatic arthritis	0.00141	0.00222	CcSEcCtD
Tiotropium—Tachycardia—Dexamethasone—psoriatic arthritis	0.00141	0.00222	CcSEcCtD
Tiotropium—Angioedema—Prednisone—psoriatic arthritis	0.00141	0.00222	CcSEcCtD
Tiotropium—Dyspepsia—Triamcinolone—psoriatic arthritis	0.0014	0.00221	CcSEcCtD
Tiotropium—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.0014	0.00221	CcSEcCtD
Tiotropium—Eye disorder—Methotrexate—psoriatic arthritis	0.00138	0.00218	CcSEcCtD
Tiotropium—Syncope—Prednisone—psoriatic arthritis	0.00138	0.00218	CcSEcCtD
Tiotropium—Urticaria—Prednisolone—psoriatic arthritis	0.00138	0.00217	CcSEcCtD
Tiotropium—Loss of consciousness—Prednisone—psoriatic arthritis	0.00136	0.00214	CcSEcCtD
Tiotropium—Angiopathy—Methotrexate—psoriatic arthritis	0.00134	0.00212	CcSEcCtD
Tiotropium—Immune system disorder—Methotrexate—psoriatic arthritis	0.00134	0.00211	CcSEcCtD
Tiotropium—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00133	0.0021	CcSEcCtD
Tiotropium—Hypertension—Prednisone—psoriatic arthritis	0.00133	0.0021	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00132	0.00208	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00132	0.00208	CcSEcCtD
Tiotropium—Myalgia—Prednisone—psoriatic arthritis	0.00131	0.00207	CcSEcCtD
Tiotropium—Arthralgia—Prednisone—psoriatic arthritis	0.00131	0.00207	CcSEcCtD
Tiotropium—Insomnia—Dexamethasone—psoriatic arthritis	0.00131	0.00206	CcSEcCtD
Tiotropium—Insomnia—Betamethasone—psoriatic arthritis	0.00131	0.00206	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.0013	0.00206	CcSEcCtD
Tiotropium—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.0013	0.00205	CcSEcCtD
Tiotropium—Paraesthesia—Betamethasone—psoriatic arthritis	0.0013	0.00205	CcSEcCtD
Tiotropium—Paraesthesia—Dexamethasone—psoriatic arthritis	0.0013	0.00205	CcSEcCtD
Tiotropium—Mental disorder—Methotrexate—psoriatic arthritis	0.0013	0.00205	CcSEcCtD
Tiotropium—Malnutrition—Methotrexate—psoriatic arthritis	0.00129	0.00203	CcSEcCtD
Tiotropium—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00128	0.00201	CcSEcCtD
Tiotropium—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00127	0.00201	CcSEcCtD
Tiotropium—Dyspepsia—Betamethasone—psoriatic arthritis	0.00127	0.00201	CcSEcCtD
Tiotropium—Urticaria—Triamcinolone—psoriatic arthritis	0.00127	0.002	CcSEcCtD
Tiotropium—Urticaria—Methylprednisolone—psoriatic arthritis	0.00126	0.00199	CcSEcCtD
Tiotropium—Oedema—Prednisone—psoriatic arthritis	0.00126	0.00198	CcSEcCtD
Tiotropium—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00126	0.00198	CcSEcCtD
Tiotropium—Infection—Prednisone—psoriatic arthritis	0.00125	0.00197	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00125	0.00197	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00125	0.00197	CcSEcCtD
Tiotropium—Back pain—Methotrexate—psoriatic arthritis	0.00125	0.00197	CcSEcCtD
Tiotropium—Shock—Prednisone—psoriatic arthritis	0.00124	0.00195	CcSEcCtD
Tiotropium—Nervous system disorder—Prednisone—psoriatic arthritis	0.00123	0.00195	CcSEcCtD
Tiotropium—Tachycardia—Prednisone—psoriatic arthritis	0.00123	0.00194	CcSEcCtD
Tiotropium—Skin disorder—Prednisone—psoriatic arthritis	0.00122	0.00193	CcSEcCtD
Tiotropium—Vision blurred—Methotrexate—psoriatic arthritis	0.00121	0.00192	CcSEcCtD
Tiotropium—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00118	0.00186	CcSEcCtD
Tiotropium—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00118	0.00186	CcSEcCtD
Tiotropium—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00117	0.00185	CcSEcCtD
Tiotropium—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00117	0.00185	CcSEcCtD
Tiotropium—Urticaria—Dexamethasone—psoriatic arthritis	0.00115	0.00181	CcSEcCtD
Tiotropium—Urticaria—Betamethasone—psoriatic arthritis	0.00115	0.00181	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00115	0.00181	CcSEcCtD
Tiotropium—Dizziness—Prednisolone—psoriatic arthritis	0.00115	0.00181	CcSEcCtD
Tiotropium—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00114	0.0018	CcSEcCtD
Tiotropium—Abdominal pain—Betamethasone—psoriatic arthritis	0.00114	0.0018	CcSEcCtD
Tiotropium—Insomnia—Prednisone—psoriatic arthritis	0.00114	0.0018	CcSEcCtD
Tiotropium—Paraesthesia—Prednisone—psoriatic arthritis	0.00113	0.00178	CcSEcCtD
Tiotropium—Pruritus—Triamcinolone—psoriatic arthritis	0.00113	0.00178	CcSEcCtD
Tiotropium—Cough—Methotrexate—psoriatic arthritis	0.00112	0.00177	CcSEcCtD
Tiotropium—Pruritus—Methylprednisolone—psoriatic arthritis	0.00112	0.00177	CcSEcCtD
Tiotropium—Dyspepsia—Prednisone—psoriatic arthritis	0.00111	0.00175	CcSEcCtD
Tiotropium—Arthralgia—Methotrexate—psoriatic arthritis	0.0011	0.00173	CcSEcCtD
Tiotropium—Chest pain—Methotrexate—psoriatic arthritis	0.0011	0.00173	CcSEcCtD
Tiotropium—Myalgia—Methotrexate—psoriatic arthritis	0.0011	0.00173	CcSEcCtD
Tiotropium—Rash—Prednisolone—psoriatic arthritis	0.00109	0.00172	CcSEcCtD
Tiotropium—Dermatitis—Prednisolone—psoriatic arthritis	0.00109	0.00172	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00109	0.00172	CcSEcCtD
Tiotropium—Headache—Prednisolone—psoriatic arthritis	0.00108	0.00171	CcSEcCtD
Tiotropium—Constipation—Prednisone—psoriatic arthritis	0.00108	0.0017	CcSEcCtD
Tiotropium—Dizziness—Triamcinolone—psoriatic arthritis	0.00105	0.00166	CcSEcCtD
Tiotropium—Dizziness—Methylprednisolone—psoriatic arthritis	0.00105	0.00166	CcSEcCtD
Tiotropium—Infection—Methotrexate—psoriatic arthritis	0.00104	0.00165	CcSEcCtD
Tiotropium—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00103	0.00163	CcSEcCtD
Tiotropium—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00103	0.00162	CcSEcCtD
Tiotropium—Nausea—Prednisolone—psoriatic arthritis	0.00103	0.00162	CcSEcCtD
Tiotropium—Pruritus—Betamethasone—psoriatic arthritis	0.00102	0.00161	CcSEcCtD
Tiotropium—Pruritus—Dexamethasone—psoriatic arthritis	0.00102	0.00161	CcSEcCtD
Tiotropium—Skin disorder—Methotrexate—psoriatic arthritis	0.00102	0.00161	CcSEcCtD
Tiotropium—Vomiting—Triamcinolone—psoriatic arthritis	0.00101	0.0016	CcSEcCtD
Tiotropium—Vomiting—Methylprednisolone—psoriatic arthritis	0.00101	0.00159	CcSEcCtD
Tiotropium—Rash—Triamcinolone—psoriatic arthritis	0.001	0.00158	CcSEcCtD
Tiotropium—Dermatitis—Triamcinolone—psoriatic arthritis	0.001	0.00158	CcSEcCtD
Tiotropium—Rash—Methylprednisolone—psoriatic arthritis	0.001	0.00158	CcSEcCtD
Tiotropium—Dermatitis—Methylprednisolone—psoriatic arthritis	0.001	0.00158	CcSEcCtD
Tiotropium—Urticaria—Prednisone—psoriatic arthritis	0.001	0.00158	CcSEcCtD
Tiotropium—Headache—Triamcinolone—psoriatic arthritis	0.000998	0.00157	CcSEcCtD
Tiotropium—Headache—Methylprednisolone—psoriatic arthritis	0.000995	0.00157	CcSEcCtD
Tiotropium—Abdominal pain—Prednisone—psoriatic arthritis	0.000995	0.00157	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000958	0.00151	CcSEcCtD
Tiotropium—Dizziness—Dexamethasone—psoriatic arthritis	0.000956	0.00151	CcSEcCtD
Tiotropium—Dizziness—Betamethasone—psoriatic arthritis	0.000956	0.00151	CcSEcCtD
Tiotropium—Insomnia—Methotrexate—psoriatic arthritis	0.000951	0.0015	CcSEcCtD
Tiotropium—Nausea—Triamcinolone—psoriatic arthritis	0.000946	0.00149	CcSEcCtD
Tiotropium—Paraesthesia—Methotrexate—psoriatic arthritis	0.000944	0.00149	CcSEcCtD
Tiotropium—Nausea—Methylprednisolone—psoriatic arthritis	0.000944	0.00149	CcSEcCtD
Tiotropium—Hypersensitivity—Prednisone—psoriatic arthritis	0.000927	0.00146	CcSEcCtD
Tiotropium—Dyspepsia—Methotrexate—psoriatic arthritis	0.000926	0.00146	CcSEcCtD
Tiotropium—Vomiting—Betamethasone—psoriatic arthritis	0.000919	0.00145	CcSEcCtD
Tiotropium—Vomiting—Dexamethasone—psoriatic arthritis	0.000919	0.00145	CcSEcCtD
Tiotropium—Rash—Betamethasone—psoriatic arthritis	0.000911	0.00144	CcSEcCtD
Tiotropium—Rash—Dexamethasone—psoriatic arthritis	0.000911	0.00144	CcSEcCtD
Tiotropium—Dermatitis—Dexamethasone—psoriatic arthritis	0.00091	0.00144	CcSEcCtD
Tiotropium—Dermatitis—Betamethasone—psoriatic arthritis	0.00091	0.00144	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000908	0.00143	CcSEcCtD
Tiotropium—Headache—Dexamethasone—psoriatic arthritis	0.000905	0.00143	CcSEcCtD
Tiotropium—Headache—Betamethasone—psoriatic arthritis	0.000905	0.00143	CcSEcCtD
Tiotropium—Pruritus—Prednisone—psoriatic arthritis	0.00089	0.0014	CcSEcCtD
Tiotropium—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00086	0.00136	CcSEcCtD
Tiotropium—Nausea—Dexamethasone—psoriatic arthritis	0.000858	0.00135	CcSEcCtD
Tiotropium—Nausea—Betamethasone—psoriatic arthritis	0.000858	0.00135	CcSEcCtD
Tiotropium—Urticaria—Methotrexate—psoriatic arthritis	0.000835	0.00132	CcSEcCtD
Tiotropium—Dizziness—Prednisone—psoriatic arthritis	0.000832	0.00131	CcSEcCtD
Tiotropium—Abdominal pain—Methotrexate—psoriatic arthritis	0.000831	0.00131	CcSEcCtD
Tiotropium—Vomiting—Prednisone—psoriatic arthritis	0.0008	0.00126	CcSEcCtD
Tiotropium—Rash—Prednisone—psoriatic arthritis	0.000793	0.00125	CcSEcCtD
Tiotropium—Dermatitis—Prednisone—psoriatic arthritis	0.000793	0.00125	CcSEcCtD
Tiotropium—Headache—Prednisone—psoriatic arthritis	0.000788	0.00124	CcSEcCtD
Tiotropium—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000775	0.00122	CcSEcCtD
Tiotropium—Nausea—Prednisone—psoriatic arthritis	0.000747	0.00118	CcSEcCtD
Tiotropium—Pruritus—Methotrexate—psoriatic arthritis	0.000744	0.00117	CcSEcCtD
Tiotropium—Dizziness—Methotrexate—psoriatic arthritis	0.000695	0.0011	CcSEcCtD
Tiotropium—Vomiting—Methotrexate—psoriatic arthritis	0.000669	0.00105	CcSEcCtD
Tiotropium—Rash—Methotrexate—psoriatic arthritis	0.000663	0.00105	CcSEcCtD
Tiotropium—Dermatitis—Methotrexate—psoriatic arthritis	0.000662	0.00104	CcSEcCtD
Tiotropium—Headache—Methotrexate—psoriatic arthritis	0.000659	0.00104	CcSEcCtD
Tiotropium—Nausea—Methotrexate—psoriatic arthritis	0.000625	0.000985	CcSEcCtD
